


Is GPT Digital Health’s Inflection Point?
While disappointment prevails, change may be in the air.

The pharmaceutical industry must move beyond a business and manufacture to become a beacon of action for the countless lives lost and impacted by the social blight of addiction.

Pause and perspective may be humanity’s most powerful tools in today’s frenetic world.

As Silicon Valley’s long-held position at the forefront of innovation and technology begins to wane, the pharmaceutical industry finds itself with an unprecedented opportunity to step up and become not just a leader but THE leader in these domains.

Home-based cardiac rehabilitation reduced mortality by 36% over facility-base care.

Ultimately, carbon and silicon might not mix very well – the struggle with technology.

AI is changing our expectations of knowledge and outcomes in medicine. So, what will tomorrow’s accepted best practices be?

The utility of simple and watched-based measurements can put blood glucose on everyone’s radar.

The rigid walls of many corporations prevent collaboration—the critical step to building the connective tissue that allows the voices of innovation to be heard and embraced.

Artificial Intelligence is at the center of medical transformation. Its ability to analyze vast amounts of data and detect patterns that would be otherwise impossible for humans to identify is an inflection point for many aspects of care.



